Pharmagreen Provides Significant Scientific Development Updates

— Pharmagreen Biotech, Inc. (PHBI), a company specializing in the development of high quality tissue cultured starter plantlets for the cannabis and hemp industry, is pleased to provide a scientific development update. Since December 2019 the company’s strategic research and development partner, Botanical Research In Motion Inc. (B.R.I.M.), has continued very successful growing trials withContinue reading “Pharmagreen Provides Significant Scientific Development Updates”

Khiron Provides Corporate Update: Surpasses 1,000 Medical Cannabis Patient Prescription Milestone

Company surpasses 1,000 medical cannabis patient prescriptions in Colombia in the first 10 weeks of sales activity, representing a milestone towards meeting patient needs in Latin America and globally Company prudently managing financial resources through reduced expenses and held approximately $20 Million in cash at the end of June 2020, after closing Q1 with $24 Million and Q4 2019 with $36 Million Received authorization forContinue reading “Khiron Provides Corporate Update: Surpasses 1,000 Medical Cannabis Patient Prescription Milestone”

Aleafia Health Approved by Janssen Pharmaceuticals to Administer Antidepressant SPRAVATO®

SPRAVATO® (esketamine) nasal spray uses the first new mechanism of action in decades to treat treatment resistant depression disorder  Aleafia Health medical clinics along with select physicians and nurses now approved to administer and prescribe, following completion of Janssen Journey certification Offering expands Aleafia’s health and wellness solutions to existing and prospective patients across Canada SPRAVATO® approved by the U.S. Food andContinue reading “Aleafia Health Approved by Janssen Pharmaceuticals to Administer Antidepressant SPRAVATO®”

Khiron to Commercialize Medical Cannabis in Peru

Khiron has received all necessary licenses and authorizations allowing full spectrum, high-CBD medical cannabis products to be exported from Colombia for import and commercialization in Peru Full spectrum high CBD medical cannabis will be supplied by Khiron Colombia and manufactured and distributed to patients under the previously announced agreement with Farmacia Universal First patient prescriptions anticipated to beContinue reading “Khiron to Commercialize Medical Cannabis in Peru”

MediPharm Labs Achieves First Sales Milestone in Australia, Global Sales for GMP Products Continue to Ramp Up in Q3 2020

In June, shipped approximately $500,000 AUD in GMP Pharma-Quality product for distribution to Australian customers Over 12 white-label supply agreements completed YTD 2020, offering multiple formulations Robust sales pipeline in Europe and Asia Pacific demonstrates demand for MediPharm Labs’ GMP certified products       — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or theContinue reading “MediPharm Labs Achieves First Sales Milestone in Australia, Global Sales for GMP Products Continue to Ramp Up in Q3 2020”

Australis Concerned Shareholders Outline Continued Major Governance Concerns with Proposed Related Party Acquisition of Passport Technology Inc.

Group of Concerned Australis Shareholders Grows to Include Duke Fu and Green Therapeutics Shareholders are encouraged to contact Laurel Hill Advisory Group at 1-877-452-7184 to register their support for the Concerned Shareholders. – A group of shareholders of Australis Capital Inc. (“Australis” or the “Company“) (CSE: AUSA), including Roger Sykes, 1703469 Alberta Ltd., Duke Fu and Green Therapeutics LLCContinue reading “Australis Concerned Shareholders Outline Continued Major Governance Concerns with Proposed Related Party Acquisition of Passport Technology Inc.”

Curaleaf Holdings Announces Closing of C$34.06 Million Private Placement of Subordinate Voting Shares

— Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading vertically integrated cannabis operator in the United States, announces today the closing of the private placement offering previously announced on July 2, 2020 (the “Offering”). Pricing of the initial tranche of the Offering was set on July 2, 2020. Under the initial tranche, subscribers purchased an aggregate ofContinue reading “Curaleaf Holdings Announces Closing of C$34.06 Million Private Placement of Subordinate Voting Shares”

AMP German Cannabis Group orders 150 kilograms of medical cannabis from Canadian Licensed Producer

– AMP German Cannabis Group Inc. (“AMP” or the “Company”) (FSE: C4T) (ISIN: CA00176G1028) (CSE: XCX) announces it has placed two orders for bulk and finished EU-GMP medical cannabis flower from a Canadian Licensed Producer (“Canadian LP”) of medical cannabis. AMP will be purchasing and importing to Germany, 50 kilograms of EU-GMP medical cannabis in September 2020 and a furtherContinue reading “AMP German Cannabis Group orders 150 kilograms of medical cannabis from Canadian Licensed Producer”

Aphria Inc. to Announce Fourth Quarter and Fiscal 2020 Financial Results on July 29, 2020

 – Aphria Inc. (“Aphria” or the “Company“) (TSX: APHA) (Nasdaq: APHA), a leading global cannabis company, will release financial results for its fourth quarter and twelve months ended May 31, 2020 on July 29, 2020.  Aphria executives will host a conference call to discuss these results at 9:00 am Eastern Time. To listen to the live call, dial (888) 231-8191Continue reading “Aphria Inc. to Announce Fourth Quarter and Fiscal 2020 Financial Results on July 29, 2020”